Related Experiment Videos
Head trauma in hemophilia. A prospective study.
Archives of Internal Medicine
|October 1, 1984
Summary
Intracranial hemorrhage (ICH) is a significant risk for hemophilia patients, especially those with severe disease. Prompt coagulation factor replacement after head trauma can prevent ICH, highlighting the need for vigilant monitoring and early intervention.
Area of Science:
- Hematology
- Neurology
- Pediatrics
Background:
- Intracranial hemorrhage (ICH) poses a serious threat to individuals with hemophilia.
- Head trauma is a common precipitating factor for ICH in this population.
Purpose of the Study:
- To prospectively record episodes of ICH and head trauma in patients with hemophilia.
- To evaluate the efficacy of coagulation factor replacement therapy in preventing ICH after head injury.
Main Methods:
- Prospective recording of ICH and head trauma events over a two-year period in 140 hemophilia patients.
- Analysis of the occurrence of ICH in relation to disease severity and timing of factor replacement therapy.
Main Results:
- 48 episodes of ICH or trauma occurred in 37 patients, predominantly those with severe hemophilia (less than 1% factor VIII or IX).
- No ICH was observed in patients receiving coagulation factor replacement within six hours of injury.
- The incidence of ICH following head trauma was 13% in this cohort.
Conclusions:
- Aggressive use of coagulation factor replacement is warranted following head trauma in hemophilia patients.
- Early recognition and prompt therapeutic intervention are crucial for managing patients at risk of ICH.